Cargando…
Cancer Therapy-Induced Cardiotoxicity—A Metabolic Perspective on Pathogenesis, Diagnosis and Therapy
Long-term cardiovascular complications of cancer therapy are becoming ever more prevalent due to increased numbers of cancer survivors. Cancer therapy-induced cardiotoxicity (CTIC) is an incompletely understood consequence of various chemotherapies, targeted anti-cancer agents and radiation therapy....
Autores principales: | Choksey, Anurag, Timm, Kerstin N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745714/ https://www.ncbi.nlm.nih.gov/pubmed/35008867 http://dx.doi.org/10.3390/ijms23010441 |
Ejemplares similares
-
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
por: Timm, Kerstin N., et al.
Publicado: (2020) -
Mechanisms of trastuzumab induced cardiotoxicity – is exercise a potential treatment?
por: Eaton, Holden, et al.
Publicado: (2023) -
Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
por: Hahn, Virginia Shalkey, et al.
Publicado: (2014) -
Cardiotoxicity of anthracycline therapy: current perspectives
por: Valcovici, Mihaela, et al.
Publicado: (2016) -
Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
por: Wu, Bin Bin, et al.
Publicado: (2022)